Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

N/ANon-phased studies

6(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(5)

Detailed Status

Completed5

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A6 (100.0%)

Trials by Status

completed583%

not_yet_recruiting117%

Recent Activity

0 active trials

Showing 5 of 6

not_yet_recruitingnot_applicable

Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment

NCT06394544

completednot_applicable

Improvement of the Selenium Supply in a Vegan Diet by Different Selenium Sources

NCT05814874

completednot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT06394544Not Applicable

Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment

Not Yet Recruiting

NCT05814874Not Applicable

Improvement of the Selenium Supply in a Vegan Diet by Different Selenium Sources

Completed

NCT05537324Not Applicable

Effects of a Single Dose of Brazil Nuts on Blood Lipids

Completed

NCT03111355Not Applicable

Effects of Genetic Variations in the Response to Brazil Nut Supplementation

Completed

NCT02121457Not Applicable

Brazil Nuts Effects on Selenium Status and Cognitive Performance

Completed

NCT00937599Not Applicable

Brazil Nut Consumed on the Metabolic Profile, Oxidative Stress and Nutritive Microcirculatory Patterns

Completed

All 6 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 6